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doi:10.1016/j.jtcvs.2004.01.034Objective: This study was undertaken to demonstrate that transmyocardial laser
revascularization of hypoperfused myocardium improves regional and global myo-
cardial function.
Methods: Cine magnetic resonance imaging was used to monitor regional wall
thickening (in millimeters) and cardiac output (in milliliters per kilogram per minute).
Cine magnetic resonance imaging was performed before and 8 weeks after transmyo-
cardial laser revascularization was applied to the hypoperfused lateral wall of the left
ventricle (target area) in a porcine model (n  9, transmyocardial laser revascular-
ization group). A second group of animals was left untreated (n 8, control group).
Results: Regional wall thickening in the target area improved after transmyocardial
laser revascularization (0.7  0.3 mm to 3.7  1.9 mm, P  .02) and was
significantly higher (P  .01) after transmyocardial laser revascularization than in
the control group, in which it did not improve (0.5  0.6 mm to 0.5  1.2 mm).
Accordingly, cardiac output and microsphere-derived myocardial blood flows were
significantly higher than in the control group (P  .01), and the amount of
triphenyltetrazolium chloride–stained myocardium was lower (P  .01).
Conclusion: Cine magnetic resonance imaging demonstrates improved global and
regional myocardial function after transmyocardial laser revascularization in a
porcine model.
Transmyocardial laser revascularization (TMLR) is approved for pa-tients with debilitating angina and high-risk candidates for a secondcoronary artery bypass surgery or angioplasty, patients in whomblockages are too diffuse to be treated with bypass alone, and somepatients in whom atherosclerosis develops after heart transplantation.Recent clinical trials have demonstrated symptomatic relief for pa-
tients with refractory angina after TMLR.1-3 However, it has not been established
whether this relief of angina is associated with improved regional function. Mag-
netic resonance imaging may be a more sensitive technique to examine this
question. Cine magnetic resonance imaging (CMR) provides high spatial and
temporal resolution4 and therefore might be suitable to accurately determine even
minor changes of myocardial function after TMLR. We hypothesized that TMLR
improves regional wall motion and preserves global function because of an im-
proved blood supply. We conducted this study with CMR to follow the changes of
left ventricular myocardial function after TMLR in a porcine model.
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All animals received care in compliance with the “Guide for the
Care and Use of Laboratory Animals” (http://nap.edu/catalog/
5140.html). One week after placement of a hollow bead into the
left circumflex artery, 17 pigs (27  2 kg, range 25-29 kg)
underwent a first CMR examination. The animals were then ran-
domly assigned to the control group (n 8) or the treatment group
(n  9). The latter underwent immediate TMLR, whereas the
former underwent a sham operation. Eight weeks after TMLR or
sham operation, a second CMR examination was performed in all
animals. Microspheres were also injected to determine myocardial
blood flow. The animals were then humanely killed, and the hearts
were removed for histopathologic assessment.
Bead Placement
A hollow bead (outer diameter 1.36-1.85 mm; lumen 1 mm, length
4 mm) was placed in the left circumflex artery, similar to a
previously described protocol.5 Before bead placement the diam-
eter of the left circumflex artery was determined and the appro-
priate bead (1.36-1.85 mm) was implanted, causing an immediate
stenosis of approximately 50% lumen reduction. Intravenous hep-
arin (300 IE/kg; Elkins-Sinn Inc, Cherryhill, NJ) was administered
during a period of 7 days in both animal groups. One week after
the procedure, a coronary angiogram was performed to document
the status (patent or closed) of the bead.
TMLR or Sham Operation
All animals were sedated with ketamine (25 mg/kg Keta Ved;
Vedco, Inc, St Joseph, Mo). With sterile technique a left lateral
thoracotomy through the fifth intercostal space was performed. A
modified high-powered (1000 W peak, 40  5 J pulse energy)
carbon dioxide laser (PLC Medical Systems, Franklin, Mass) was
used to create 30 5 laser channels uniformly distributed over the
left ventricular lateral wall. Transmural penetration was confirmed
by transesophageal echocardiography. Hemostasis was obtained
by manually applied gentle pressure, and the thorax was closed in
Figure 1. Regional myocardial thickening assessed w
cords between end-diastole and end-systole determine
cavity; LCx, left circumflex artery.layers.
392 The Journal of Thoracic and Cardiovascular Surgery ● SeptImage Acquisition and Analysis
During image acquisition, left ventricular end-diastolic pressure,
aortic pressure, and heart rate were monitored. CMR was per-
formed in a 1.5-T scanner (Siemens Vision; Siemens AG, Er-
langer, Germany). A phased-array radiofrequency body coil was
used for imaging. Cine imaging was performed with an electro-
cardiographically gated segmented cine sequence (TR/TE 33/6 ms,
flip angle 25°, matrix 87  128, pixel size 2  1.4 mm2) and a
slice thickness of 7 mm without gap. Temporal resolution was 15
frames/beat. The entire heart was covered from base to apex with
8 to 10 short-axis slices, which were defined as the image plane
perpendicular to the left ventricular long axis.
Functional parameters were determined in a blinded setting
with MASS-software (version 1.0; Leiden University Medical
Center, Leiden, The Netherlands). Endocardial and epicardial bor-
ders of the left ventricle were defined manually in each ED and ES
frame by an observer who was blinded to the status of the animal.
A stack of contiguous slices was used to create a 3-dimensional
surface rendering of the left ventricular volume to determine
cardiac output (in milliliters per minute per kilogram) and ejection
fraction (as a percentage). Regional wall thickening was analyzed
in the septal (remote) myocardium and in the lateral wall (target
region) according to the centerline method.6 The circumference of
the myocardial short axis was divided in 100 cords aligned per-
pendicular to the endocardial and epicardial surface (Figure 1).
Myocardial thickening was calculated by the difference between
end-diastolic and end-systolic lengths of each cord. Reduced thick-
ening in the lateral wall was defined as thickening of 1.9 mm or
less, which is 2 SDs below the thickening of the healthy left ventric-
ular myocardium in a weight-matched control group (myocardial
thickening in the lateral wall 3.5 0.8 mm and 3.8 0.7 mm in the
septal wall, unpublished observations). The remote region was de-
fined as the 25 from a total of 100 cords opposing the target region.
Determination of Blood Flow and Histopathology
Myocardial blood flow (in milliliters per gram per minute) was
he modified centerline method; changes in length of
kening. RV, Right ventricular cavity; LV, left ventricularith t
thicassessed in the target and remote myocardium (Figure 2). Trans-
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microspheres as described earlier,7 and endocardial/epicardial
blood flow ratios were calculated. The necrotic area was deter-
mined by planimetry in 6 to 8 slices of 10-mm thickness according
to the double oblique short-axis orientation obtained by CMR. The
necrotic tissue was stained with triphenyltetrazolium chloride
(TTC). The volume of the necrosis was determined by the average
area of the TTC-unstained area at the basal and apical surface of
the slice multiplied by the thickness of the slice. In each animal no
more than 1 or 2 slices contained unstained myocardium.
Statistics
Data were analyzed with the SPSS statistical software package
(release 10; SPSS Inc, Chicago, Ill). All data are mean  SD.
Follow-up data within a group and data between groups at a given
time point were tested with 1-factor analysis of variance. Fol-
low-up data between groups were tested with 2-factor (time,
group) analysis of variance with repetition.
Results
One week after bead placement, the angiograms showed
decreased and delayed antegrade coronary opacification
without substantial collateral filling in all animals. Hemo-
dynamic data and CMR-derived volumetric data are dis-
played in Table 1. Data for regional wall thickening are
displayed in Table 2. At 1 week the number of dysfunctional
cords (defining the extend of the ischemic region) between
the two groups was not significantly different (TMLR 21 
8, control 17  4, P  .4). The number of dysfunctional
cords decreased significantly in the treated group (6  6,
P  .02) but not in the control group (14  3, P not
significant) at the 8 week follow-up. The difference between
the groups after 8 weeks was significant (P  .04).
Table 3 shows data on myocardial blood flow. Myocar-
dial blood flow in the remote myocardium was significantly
higher than in the ischemic zone in both groups. Transmural
blood flows in the target and remote regions were signifi-
cantly higher in the treated animals than in the control
group. The endocardial/epicardial blood flow ratio was sig-
nificantly higher in the treated ischemic region than in the
ischemic untreated region of control animals.
At autopsy, all beads in both groups were inspected and
found to be closed. TTC-staining revealed “patchy” un-
stained myocardium in the subendocardial region, indicat-
ing minimal necrosis within the target area, in all animals.
Planimetric examination of the TTC-stained area demon-
strated a significantly higher amount of necrotic tissue in
control animals (Table 3).
Discussion
In this study we used CMR to demonstrate changes in
myocardial function after TMLR of ischemic myocardium.
Both the ischemic and the remote myocardial regions
showed regional improvement relative to a control group
after TMLR treatment. Accordingly, myocardial blood flow
The Journal of Thoraciwas increased in the ischemic and remote areas, and the
amount of left ventricular necrosis was smaller than in the
control group. The regional improvement was paralleled by
a preserved global myocardial function in the treated group.
In addition, TMLR limited the extension of the necrosis in
our model, as indicated by the reduced amount of necrosis
and dysfunctional cords in the treated group.
The reduced myocardial function in the remote zone of
the untreated control group is consistent with clinical re-
ports by Kramer and colleagues,8 who found impaired re-
gional function of the remote myocardium paralleling the
reduced function of an opposing infarcted region. Two
potential mechanisms could explain our findings in the
remote area: reduced coronary flow in the remote area,9 as
confirmed by our microsphere data, and increased loading
and mechanical tethering of the remote region,10 repre-
sented by a decreased thickening in this area in our control
group.
In our study there was improved blood supply after
TMLR. The exact mechanism remains controversial and
may include angiogenesis.11 TMLR-induced angiogenesis
has been shown in ischemic11 and nonischemic myocardi-
um.12 However, the mechanisms of neovascularization after
TMLR are not well understood. An inflammatory response,
with liberation of cytokines and growth factors and upregu-
lation of receptors, has been proposed as a possible mech-
anism. There was an increased endocardial/epicardial blood
flow ratio in ischemic myocardium in our treated group
relative to control animals. Because there was no significant
difference in left ventricular end-diastolic pressure between
the groups, this diminished blood flow ratio cannot be
explained by an increased left ventricular end-diastolic pres-
sure in the untreated group. A reduced amount of recruitable
endocardial microvasculature or an impaired ability to dilate
Figure 2. Schematic diagram of ischemic (bead-dependent) and
remote myocardial regions in left ventricular short-axis position.
LV, Left ventricular cavity; RV, right ventricular cavity; LCx, left
circumflex artery.because of perivascular fibrosis, combined with a more
c and Cardiovascular Surgery ● Volume 128, Number 3 393
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of control animal, may explain the decreased endocardial/
epicardial blood flow ratio.
Clinical Implications and Conclusion
Most clinical trials have demonstrated relief of angina after
TMLR.13 TMLR, in particular with the Ho:YAG laser and
the carbon dioxide laser used in this animal study, has
therefore been approved by the Food and Drug Administra-
tion. This is in contrast to percutaneous myocardial laser
revascularization, which is still considered investigational
and has not been approved by the Food and Drug Admin-
istration. Not all trials assessed quantitative segmental myo-
cardial function2,3 and some used different methods, with
variable results regarding an improved outcome after
TMLR.1,14
The variable results may be explained by less precise
TABLE 1. Catheter-derived hemodynamic variables and vo
TM
Heart rate (beats/min) 90
Cardiac output (mL/[kg · min]) 116
Mean aortic pressure (mm Hg) 86
Left ventricular end-diastolic pressure (mm Hg) 12
Ejection fraction (%) 56
Untreated group n  6, treated group n  7.
*P  .01 within group.
†P  .01 between groups.
TABLE 2. Regional myocardial thickening (mm) in the targ
Before TMLR
TMLR
Target myocardium 0.7 0.3
Remote myocardium 4.9 0.9
*P  .01 for baseline to follow-up.
†P  .05 between groups.
‡P  .05 for baseline to follow-up.
TABLE 3. Microsphere-derived regional myocardial blood
the target and remote myocardium and percentage necro
myocardium after TMLR
Group
Blood flow (mL/[g · min])
TMLR Control
Target myocardium 0.6 0.3* 0.2 0.1
Remote myocardium 1.2 0.1*‡ 0.8 0.2‡
*P  .01 versus control group.
†P  .05 versus TMLR group.
‡P  .01 versus target myocardium.quantification of global and segmental function with quali-
394 The Journal of Thoracic and Cardiovascular Surgery ● Septtative or other quantitative methods. In vivo and in vitro
studies have shown that CMR is a valid and reproducible
method.15 It is dimensionally accurate and needs no geo-
metric assumptions, in contrast to 2-dimensional methods.
Recently, CMR has been shown in a patient study to have a
significant higher accuracy in the assessment of segmental
myocardial function than echocardiography.4 Left ventric-
ular function is directly correlated with mortality.15 CMR-
derived data of myocardial function thus may offer a good
surrogate to stratify patients who will benefit from TMLR.
With quantitative CMR we demonstrated improved re-
gional and global myocardial functions of hypoperfused and
remote myocardium after TMLR in a porcine model. These
changes were paralleled by improved blood flow and less-
ened necrosis in the target myocardium. Recent publications
regarding a porcine model of chronic ischemia have dem-
16
s determined with CMR
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Pcontractility17 12 weeks after TMLR. These studies further
support our data. On the basis of our results, we recommend
CMR for the assessment of regional myocardial function as
a surrogate end point in upcoming clinical TMLR trials.
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